The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of mogamulizumab, an anti-CCR4 antibody targeting regulatory t cells in advanced cancer patients.
 
George Plitas
Consulting or Advisory Role - Kyowa Hakko Kirin; Lycera; Vesuvius Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center
 
Kenmin Wu
No Relationships to Disclose
 
Jeremie Carlson
No Relationships to Disclose
 
Nicholas Cimaglia
No Relationships to Disclose
 
Monica Morrow
Honoraria - Genomic Health
 
Alexander Y. Rudensky
Stock and Other Ownership Interests - FLX Bio; Surface Oncology
Consulting or Advisory Role - FLX Bio; Surface Oncology; Vedanta Biosciences
Patents, Royalties, Other Intellectual Property - University of Washington
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb